Youth Nicotine Use: A Growing Public Health Concern

Nov.25.2022
Youth Nicotine Use: A Growing Public Health Concern
Teenagers in the US are increasingly using e-cigarettes and flavored tobacco products, leading to concerns of nicotine addiction.

According to data from the Centers for Disease Control and Prevention, approximately 1,600 young people in this country will try their first cigarette each day.


According to the 2022 National Youth Tobacco Survey, "3.7% of middle and high school students - about 1 million in total - have tried combustible tobacco products such as cigars or cigarettes," reported Ken Alltucker of USA Today. This isn't even their most popular choice. Survey data shows that e-cigarettes are by far the most popular choice for school-age children. During the study period from January 18 to May 31, "nearly 3.1 million middle and high school students tried e-cigarettes or other tobacco products." Among adolescent e-cigarette users, "85% said they use flavored e-cigarettes, with over half using disposable e-cigarettes.


The number of people using very specific tobacco products is much higher among certain groups, and this is not a coincidence," said Matthew L. Myers, President of the non-profit organization, the Campaign for Tobacco-Free Kids. "This is directly related to the advertising positioning of the tobacco industry.


It is truly concerning that 3 million children are using these products," added Erika Sward, Assistant Vice President for National Advocacy at the American Lung Association.


Seasoning products have fueled this epidemic from the beginning," said Dennis Henigan, Vice President of Law and Regulatory Affairs for the Campaign for Tobacco-Free Kids, to USA Today.


Flavored electronic cigarettes are causing a new generation of Americans to become addicted to nicotine," wrote Margaret Foti, CEO of the American Association for Cancer Research, in a recent STAT news op-ed.


In the past decade, there has been a significant increase in the number of teenagers, young adults, and individuals who have never previously used tobacco products, using flavored electronic cigarettes and other electronic nicotine delivery systems, reaching its peak among high school students in 2019," said Forte. "While the use of these products saw a decline during the COVID-19 pandemic, their popularity is once again on the rise.


According to a report by USA Today, although the US Food and Drug Administration issued a ban in 2020 prohibiting the use of flavor cartridges in e-cigarettes that deliver nicotine, the industry seems to have found a way around this regulation by selling lab-made nicotine instead of tobacco-made nicotine. Earlier this year, the FDA warned synthetic nicotine manufacturers and retailers about the illegal sale and marketing of these products.


Swod warned that, "Until we address the root causes - wholesalers, manufacturers, and distributors - we will continue in this cycle" of young people vaping.


Foti wrote: "Prohibiting flavored (electronic nicotine delivery systems) products would be a powerful strategy for reducing their appeal to young people, and reducing the appeal of these products must be an urgent public health priority.


In late October, the American Cancer Society and the American Society of Clinical Oncology released an updated joint policy statement calling for urgent action to prevent further nicotine addiction. "It includes a ban on all flavored electronic nicotine delivery system products and strengthened regulatory enforcement," she added. The research cited by Foti suggests that young people who use these products are approximately three times more likely to start smoking traditional cigarettes than their peers who do not use them.


As cancer experts, we are increasingly concerned about the growing use of electronic nicotine delivery systems, as adolescents and young people who may not have used traditional tobacco products are now using these devices and risking addiction to nicotine, which in turn could lead to long-term use of combustible tobacco," she added.


According to an article on NewsForKids.net, a platform created by teachers to inform children about news, the problems caused by e-cigarettes could last a lifetime for those who have never smoked before. In the US, cigarettes and e-cigarettes can only be sold to adults, but many companies are attempting to lure young people into trying e-cigarettes by using flavors such as candy or cotton candy, making the e-liquid look like children's juice or candy. Therefore, many young people are starting to use e-cigarettes, believing them to be safe.


It is dangerous for young people's brain development to be exposed to nicotine. The Mayo Clinic states that for some individuals, any amount of tobacco use can quickly lead to nicotine addiction. This is the reality our children are facing.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in the translator's ability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan or foreign-related issues and statements.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York State will extend its tobacco products tax to “alternative nicotine products,” including tobacco-free nicotine pouches, from September 1, 2026, at a rate of 75% of the wholesale price. Distributors, wholesalers and retailers must also inventory products held as of 11:59 p.m. on August 31 and pay a floor tax. Vapor products are excluded from the new category and remain subject to New York's separate 20% supplemental sales tax on the retail price.
Aug.26
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Product | PMI Japan Expands ZYN by IQOS Strength Portfolio With Strong Series, Increasing Lineup to 12 Products
Philip Morris Japan (PMJ) has expanded the ZYN by IQOS oral tobacco pouch portfolio in Japan with four new ZYN Strong products, adding a third intensity level alongside the existing Low and Medium ranges. The Strong series first entered selected duty-free channels in Japan on July 1, 2026, before expanding to IQOS stores, the ZYN Online Store and selected tobacco retailers from August 18. The expansion increases the Japanese ZYN by IQOS lineup from eight to 12 products.
Aug.20
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
Product | VAPORESSO Launches PRIX MTL Pod, With NFC Version Linking Interchangeable Panels to On-Screen Animations
VAPORESSO introduced the PRIX MTL pod system in August 2026 in two versions, Filter and NFC. The Filter version allows users to switch between a conventional drip tip and a filter tip, while the NFC version links interchangeable panels to matching on-screen animations. PRIX features a 2,600mAh battery, a 5.5ml pod, a 0.87-inch TFT display and a maximum output of 40W, alongside Dual Mesh Impact Pods capable of operating at two resistance and power configurations. VAPORESSO's French website lists MSRP at $39.99 for the Filter version and $49.90 for the NFC version.
Market
Aug.24 by 2Firsts Perspectives
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11